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Generally, all bilaterans examined have similar conservation of HOX protein structure, 
function, expression, and requirement. However, at the level of being the same, it is 
unknown whether the HOX protein, Antennapedia, is required for tarsus determination in 
Drosophila melanogaster as in Tribolium casteneum, or whether the requirement of HOX 
proteins in determination of body parts diverges in insects.  I proposed to use a heat 
shock-inducible nanobody (UAS- NSlmb-vhhGFP4 driven by hsp-GAL4) activated during 
the third larval stage in all cells to degrade thoracically expressed HOX proteins (Sex 
combs reduced, Antennapedia, and Ultrabithorax) tagged with green fluorescence protein 
(GFP) derivatives; GFP, YFP, CFP, or 17 amino acid epitope of GFP. Due to difficulties 
in establishing CRISPR mediated homologous recombination, only the initial steps have 
been completed, but the system is now established to determine whether HOX 
requirement for tarsus determination is conserved in insects. 
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 Advantages of Drosophila as a Model Organism 1.1
Drosophila melanogaster, the common fruit fly, was first documented as being used in 
1901 by William Castle’s laboratory at Harvard. However, Thomas Hunt Morgan is 
considered to be the “father” of Drosophila research (Kohler, 1994). Morgan began using 
Drosophila for the experimental study of evolution around 1906 and shortly thereafter he 
discovered the white gene (flies with this mutation have white eyes instead of red). This 
led to fruit flies making important contributions to the fields of medical and scientific 
research, including molecular biology, cell biology, developmental biology, and 
population biology (Stephenson & Metcalfe, 2013). Morgan won the Nobel Prize in 
Physiology or Medicine in 1933 “for his discoveries concerning the role played by the 
chromosome in heredity” and his students also went on to make key advances in genetics 
and helped to expand Drosophila as the leading genetic system. One of whom, Muller, 
won a Nobel Prize in Physiology or Medicine in 1946 “for the discovery of the 
production of mutations by means of x-ray irradiation” and is also credited with the 
development of balancer chromosomes. The past few decades has seen Drosophila 
become a predominant model used to understand how genes direct the development of an 
embryo from a single cell to a mature multicellular organism (Edward B. Lewis, 
Christiane Nüsslein-Volhard, and Eric F. Wieschaus won a Nobel Prize in Physiology or 
Medicine 1995 “for their discoveries concerning the genetic control of early embryonic 
development”). Many of the processes that direct development within the fly have been 
conserved through evolution and are strikingly similar to the processes that direct 
development in all organisms. The Drosophila genome sequence was first released in 
March 2000 and is freely available, along with annotations, via “Flybase”, an online 
database dedicated to Drosophila (dos Santos et al., 2014). Currently, it is estimated that 
there are  ~14,000 genes in Drosophila (Adams et al., 2000). The past century has seen a 
huge range of genetic tools become available for Drosophila that match or surpass those 
for any other multicellular organisms. There are vast assortments of strains containing 
endogenous mutations available from stock centres or the labs that generated them which 





Drosophila have a relatively short life cycle and are inexpensive and easy to keep. This 
means that genetic experiments that would take months or even years in vertebrate 
models, such as mice, Xenopus, or zebrafish, can be completed in a matter of weeks. 
Female flies can lay up to ~100 eggs per day for up to 20 days and it takes approximately 
10 days at 25ºC for an embryo to develop into a fertile adult fly (Dahmann, 2008). Thus, 
it is relatively easy to generate large numbers of embryos (only ~500 µm in size) or flies 
for an experiment (Jennings, 2011).  Furthermore, unlike other vertebrate models, 
Drosophila is not subject to animal licensing laws and there are generally very few 
restrictions on their use in the laboratory as there are minimal ethical and safety issues 
(Jennings, 2011). Additionally, individual flies are easily manipulated if necessary 
through safe anaesthetisation with carbon dioxide. Fly strains are maintained through 
living stocks (Jennings, 2011).  
 Genetic Tools Available in Drosophila 1.2
Prior to the 1940s, Drosophila was used as a major model organism in the field of 
genetics (Hartwell et al., 2004). However, after the establishment of recombinant 
technology with bacteria and virus models, Drosophila again became a prominent model 
organism for the study of developmental genetics (Hartwell et al., 2004). The renewed 
interest in Drosophila was because genes previously identified by mutant alleles that had 
been shown to be important in development or behavior could now be isolated and 
analyzed using recombinant technology (Hartwell et al., 2004). The isolation of 
Drosophila genes led to the discovery that similar genes were found in higher organisms 
(Hartwell et al., 2004).  
1.2.1 Balancer Chromosomes 
In Drosophila, crossing-over only occurs in females. The absence of crossing-over in 
males allows linkage relationships to be maintained by ensuring strict male inheritance 
(Hartwell et al., 2004). In females, only one or two crossing-over events typically occur 
on each major chromosome arm per meiosis. To help maintain linkage, “balancer 
chromosomes”, which contain multiple, overlapping inversions, are used. Balancer 





balancer through crosses, as well as a recessive lethal mutation, such that flies 
homozygous for the balancer chromosome don’t survive (Herman et al., 1976). This 
allows no recombinant chromosomes to be passed to the next generation, and therefore, 
balancer chromosomes and their homologs are inherited as intact single mendelian units 
(“An Introduction to Balancers,” Bloomington Drosophila Stock Center website). 
Balancer chromosomes are essential in maintaining stocks of flies carrying lethal 
mutations and in many genetic manipulations. 
1.2.2 Transgenesis: P Element 
“Transgenesis” is a general term referring to a group of technologies that allows the 
reintroduction of DNA into the genome of an organism. P element mediated 
transformation was the first of these methods to be developed. Originally identified as a 
tool for mutagenesis, Rubin & Spradling (1982) recognized the ability to use P elements 
for transgenesis. The transposase enzyme causes the excision of a P element from its 
initial position in the host genome and the reinsertion of the element randomly at another 
position in the genome. To prevent uncontrolled transposition, the two parts of the P 
element, the transposase enzyme and the recognition sequences for transposase action, 
are separated on two separate plasmids, the P element plasmid and a helper plasmid 
(Karess & Rubin, 1984). This method has a wide variety of applications, including 
enhancer trapping, gene-tagging, targeted misexpression, RNA interference (RNAi) 
delivery, and homologous recombination/gene replacement.  
1.2.3 LoxP/Cre 
Advances in the field of transgenesis have improved fly transgenic methods. The P 
element method is limited by the small size of the DNA that can be integrated, and that 
the insertion site cannot be controlled. Methods using recombinases and integrases are 
integration site specific (Venken & Bellen, 2007).  In one such method, the loxP/Cre 
system is composed of the recombinase, Cre, which recognizes the target site, loxP. 
When the genome has a single loxP site, Cre can target a transgene to this site that also 
has a loxP site.  When a transgene is integrated in DNA and contains two flanking loxP 
sites, the Cre recombinase removes the transgene.  However, when the Cre recombinase 





multiple, sequential recombination events are required, as is the case for this project, the 
loxP scar will interact with other loxP sequences in the genome causing chromosomal 
deletions and inversions (Delneri et al., 2000, 2003). A mutant loxP, lox2272,  does not 
recombine with the standard loxP site but is still recognized by Cre recombinase to allow 
multiple, sequential recombination events (Lee & Saito, 1998; Missirlis et al., 2006). 
1.2.4 GAL4/UAS  
Transgenesis can also be used to induce ectopic misexpression of genes, that is, abnormal 
temporal expression or expression in cells or tissues outside where the gene is normally 
expressed. For example, fusing a heat-shock promoter (hsp) to a gene renders the 
expression of the gene to be temperature-dependent and ubiquitous (Bonner et al., 1984). 
An improved technique allows gene expression to be controlled both temporally and 
spatially using a yeast transcriptional activator GAL4 (Brand & Perrimon, 1993). In the 
GAL4/UAS system, GAL4 expression induces a GAL4 responsive promotor, or upstream 
activation sequence (UAS). Depending on the promoter used, GAL4 can be expressed in 
a specific pattern, at a specific time, (example using a hsp), or ubiquitously (example 
using the armadillo promoter). Genes that are downstream of a UAS sequence can only 
be activated by GAL4, and therefore, control of the expression of a gene of interest at 
almost any stage of development and in any tissue is possible (Ryder & Russell, 2003). 
To further refine the temporal expression of GAL4 activity, a temperature-sensitive (ts) 
GAL80
ts 
is often used (Matsumoto et al., 1978). GAL80 protein binds to GAL4, 
repressing the activation of gene expression (Brand & Perrimon, 1993). Therefore, only 
at high temperatures does GAL80
ts
 dissociate from GAL4 allowing gene expression.  
1.2.5 RNAi 
Contrary to ectopically expressing genes, is to silence gene expression. One method to 
accomplish this is with inducible RNA interference (RNAi). RNAi allows silencing of a 
gene without having to mutate the endogenous copy by injecting double-stranded RNA 
into an embryo which then acts as a degradation template for the host mRNA (Fire et al., 
1998; Yang et al., 2000). However, induction of RNAi in Drosophila by injection has 
problems associated with it, including that the effect is not stably inherited and that 





development (Kennerdell & Carthew, 1998). In addition, RNAi is not very efficient and 
results in off-target effects (Qiu et al., 2005).  
1.2.6 Transgenesis: Zinc-finger and Transcription Activator-like 
Effector Nucleases 
The big disadvantage of P element or any transposon-mediated system of transgenesis, is 
that the DNA is incorporated randomly in the genome. The expression of the transgene is 
then susceptible to the chromatin environment around the insertion site, referred to as 
position effect. The use of site-specific recombinases allows the insertion of all constructs 
at the same position in the genome (Venken & Bellen, 2007). But perhaps the best 
approach in transgenesis is the ability to modify the endogenous locus through 
homologous recombination (HR). HR is a powerful tool for genome editing in which a 
double stranded break (DSB) in the endogenous DNA is repaired by an exogenous repair 
template resulting in an exchange of nucleotide (nt) sequence (Capecchi, 1989). DSBs 
stimulate cellular DNA repair mechanisms, including either HR when a repair template is 
supplied, or error-prone non-homologous end joining (NHEJ; Lieber, et al., 2003; West, 
2003). The first method of creating DSBs in the Drosophila genome was purely genetic, 
using a yeast I-SceI endonuclease (Bellaiche et al., 1999; Rong & Golic, 2000). However, 
this method is very labour intensive and inefficient. Some improvements for creation of 
site-specific, targeted DSBs have since been discovered using nucleases like Zinc-finger 
nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs). ZFNs are 
protein fusions between the FokI nuclease and three zinc-finger DNA-binding domains 
that introduce sequence specificity (Bibikova et al., 2003). TALENs are a protein fusion 
between the FokI nuclease and a transcription activator-like effector (TALE; Christian et 
al., 2010). These two methods, although useful, are labour-intensive and time-consuming. 
1.2.7 Transgenesis: CRISPR 
A simple and more efficient alternative has recently emerged to induce targeted DSBs: 
CRISPR (clustered regularly interspaced short palindromic repeats). In type II CRISPR 
systems, short sequences complementary to foreign DNA, CRISPR RNA (crRNA), and 
trans-activating CRISPR RNA (tracrRNA), direct sequence-specific cleavage of 





al., 2013; Gratz et al., 2013; Figure 1.A). The Cas9 protein requires a 20 nt guide 
sequence complementary to the target site within the crRNA and a conserved 
dinucleotide-containing protospacer adjacent motif (PAM) sequence, NGG, upstream of 
the crRNA binding region (Jinek et al., 2012). On average, this sequence (NGG) occurs 
every 8 bases in the DNA and recent reports suggest that this requirement may be relaxed 
to include NAG sequences, increasing the number of potential target sites (Mali et al., 
2013a). Additionally, Cas9 nucleases may be engineered with altered PAM specificities 
(Kleinstiver et al., 2015). This allows the system to be used to target virtually any 
sequence for cleavage simply by redesigning the crRNA. The system has been simplified 
into a minimal two-component system – Cas9 and a chimeric RNA (chiRNA) that 
includes both the crRNA and the tracrRNA from Streptococcus pyogenes (Jinek et al., 
2012; Figure 1.B). The CRISPR system has been used to accomplish efficient genome 
engineering in many organisms, including but not limited to Drosophila (Chang et al., 
2013; Cho et al., 2013; Cong et al., 2013; DiCarlo et al., 2013; Ding et al., 2013; 
Friedland et al., 2013; Gratz et al., 2013; Guo & Li, 2015; Hwang et al., 2013; Jiang et 
al., 2013; Jinek et al., 2012; Mali et al., 2013b; Wang et al., 2013).  Optimization to 
improve specificity and efficiency has seen development of transgenic flies expressing 
Cas9 and/or chiRNA. The germline-specific nanos (nos) promoter and the ubiquitous 
actin5C (act) promoter are two commonly used promoters to drive Cas9 expression in 
Drosophila (Kondo & Ueda, 2013; Port et al., 2014; Ren et al., 2013).   
 CRISPR: A History 1.3
CRISPRs are the most efficient method of genome editing to date. A series of repeats 
were first discovered in the Escherichia coli genome in 1987 (Ishino et al., 1987). They 
were originally termed Short Regularly Spaced Repeats (SRSRs) and in 2000, these 
repeats were found to exist in the genomes of other archaea and bacteria (Mojica & Díez-
Villaseñor, 2000). CRISPR loci have been found in 80% archaeal genomes and about 
40% of bacterial genomes sequenced to date (“CRISPRs Database,” 2014).  In 2002, 
SRSRs were renamed CRISPRs when it was established that the three major components 
of a CRISPR locus are: cas genes (encode a nuclease), a leader sequence, and a repeat-






Figure 1. CRISPR System.  
(A) In the type II CRISPR system, transcripts from the CRISPR repeat arrays are 
processed into crRNAs, each harboring a variable sequence homologous to that of the 
invading DNA, known as the “protospacer” sequence, and part of the CRISPR repeat. 
Each crRNA hybridizes with a second RNA, known as the tracrRNA, and these two 
RNAs complex with the Cas9 nuclease. The crRNA directs Cas9 to cleave 
complementary target-DNA sequences, if they are adjacent to short sequences known as 
protospacer adjacent motifs (PAMs). (B) The system was further simplified to a two-
component system that utilizes a chiRNA, or guide RNA, which is a fusion of the crRNA 
and tracrRNA, and Cas9. The chiRNA uses 20 nt of sequence that corresponds to the 
target DNA sequence (Jinek et al., 2012. Reprinted with permission from AAAS). N.B. 





that the CRISPR/Cas system has a role in bacterial adaptive immunity and worked 
analogously to the eukaryotic system of RNAi, with the spacers serving as a template for 
RNA molecules (Bolotin et al., 2005; Makarova et al., 2006; Mojica et al., 2005; Pourcel 
et al., 2005). Barrangou et al. (2007) showed that the resistance specificity was due to the 
spacer DNA sequence coinciding to phage DNA sequence.  The study of CRISPR/Cas 
relationships identified 3 major systems, Type I, Type II, and Type III, which all have 
three stages: adaptation, expression and interference (Figure 2; Makarova et al., 2011). 
The adaptation stage involves the recognition of invading DNA and then incorporation of 
some of the invading DNA sequence, called spacers, into the CRISPR array by Cas 
proteins (Makarova et al., 2011). The CRISPR array is then transcribed in the expression 
stage to form a long pre-CRISPR RNA (pre-crRNA) that is processed and assembled into 
one of three crRNA/Cas riboproteins (Makarova et al., 2011). The Type I, Type II, or 
Type III crRNA/Cas riboproteins interfere with invading DNA, cleaving it at the target 
sites (Makarova et al., 2011).  The Type II system, which uses the nuclease, Cas9, was 
used by researchers in 2012 to edit the genome of human tissue culture cells (Jinek et al., 
2012). In type II CRISPR systems, short sequences complementary to foreign DNA, 
crRNA, and tracrRNA, direct sequence-specific cleavage of exogenous DNA through 
interaction with a Cas9 nuclease (Jinek et al., 2012; Figure 1.A). Jinek et al. (2012) then 
further simplified the type II system to be a minimal two-component system – Cas9 and a 
chimeric RNA (chiRNA) that is a fusion of the crRNA with the tracrRNA from 
Streptococcus pyogenes (Figure 1.B). Since then, the CRISPR system has been exploited 
and used efficiently in many organisms and cells, including, yeast (DiCarlo et al., 2013),  
zebrafish (Chang et al., 2013; Hwang et al., 2013), mice (Wang et al., 2013), nematodes 
(Friedland et al., 2013), plants (Jiang et al., 2013), monkey embryos (Guo & Li, 2015), 
human stem cells (Cho et al., 2013; Cong et al., 2013; Ding et al., 2013; Jinek et al., 
2012; Mali et al., 2013b) and Drosophila (Gratz et al., 2013).  More importantly, 
CRISPR has interesting applications in medicine, for example curing genetic disease. 
Mice were cured of a liver disorder (Yin et al., 2014). Libraries of tens of thousands of 
guide RNA (chiRNA) are already available for human genes (Pennisi, 2013) and the 






Figure 2. The Three Stages of CRISPR–Cas Action.  
CRISPR–Cas systems act in three stages: adaptation, expression and interference. 
Adaptation begins by recognition of invading DNA by Cas1 and Cas2 and integration of 
short sequences in a CRISPR array. Expression involves transcription of the CRISPR 
array into a long pre-crRNA. CrRNA processing and interference (nucleic acid cleavage) 







 Development of Drosophila 1.4
Fruit flies like to lay their eggs near the surface of fermenting (ripening) foods or other 
organic materials. Drosophila, like butterflies and moths, are holometabolous insects, 
which mean that they undergo a four stage life cycle; egg, larva, pupa, and adult fly 
(Figure 3). At 25ºC, the fertilized embryo develops in the egg for around one day before 
hatching as a larva. The initiation of Drosophila embryogenesis is characterized by a 
syncytial blastoderm, where nuclei divide in a multinucleate common cytoplasm for 
around 2 hours. During this syncytial blastoderm stage, a subset of nuclei cellularizes 
gaining a plasma membrane. These cells are the pole cells and are the progenitors of the 
germ line, the sperm and ova (Campos-Ortega & Hartenstein, 1997). After a few more 
nuclear divisions, the rest of the nuclei cellularize to form the cellular blastoderm. The 
cellular blastoderm then undergoes gastrulation, giving rise to the three germ layers. For 
the next 6 hours, germ band elongation takes place, in which the ventral epidermis 
lengthens and mitotic divisions begin to occur. The neuroblasts are determined, the 
embryo becomes segmented, and the cephalic furrow begins formation. Subsequently, the 
head features start to develop and the neuroblast complete their formation. Germ band 
retraction begins at ~9.5 hours post-fertilization which involves ventral closure and 
segment formation within the embryo.  The central and peripheral nervous systems 
become differentiated, followed by dorsal closure of the midgut and epidermis. Head 
involution begins, and dorsal closure is completed. Next, the ventral nerve cord shortens 
and air fills the tracheal tree. Embryogenesis concludes with the hatching of a first instar 
larva at 21-22 hours after fertilization. Over the next five days, the larva eats and grows, 
going through two molts, to become a second and third instar larva, until it pupates. 
While a pupa, it undergoes metamorphosis into the adult fly over the course of four days. 
Most of the embryonic and larval tissue is destroyed during metamorphosis, and the adult 
tissues (e.g. wing, leg, eye) develop from groups of cells known as imaginal discs. 
Imaginal discs are derived from cells set aside during embryogenesis that form the adult-
specific structures. During the larval stages and metamorphosis, the imaginal cells 
proliferate to form differentiated discs of cells. When metamorphosis is complete, the 






Figure 3. Schematic of the Stages of the Drosophila Life Cycle.  
After fertilization and the initiation of embryogenesis, an embryo hatches as a first instar 
larva before it molts twice to form a second and third instar larva. The third instar larva 
pupariates into a pupa and then ecloses as a mature adult fly. This figure was adapted 







 The Drosophila Genome 1.5
The Drosophila genome has been well characterized and was one of the first eukaryotic 
genomes to be sequenced, closely following yeast (Saccharomyces cerevisiae) and the 
nematode (Caenorhabditis elegans) (Adams et al., 2000; The C. elegans Sequencing 
Consortium, 1998; Goffeau et al., 1996). The DNA of Drosophila is broken up into six 
units: three autosomes (chromosome 2, 3, and 4), two sex chromosomes (X and Y; Figure 
4) as well as the mitochondrial genome. Out of ~180 Mb, 120 Mb is euchromatin, which 
is mainly located on the two large autosomes (2 and 3) and the X chromosome (Adams et 
al., 2000). The small fourth chromosome contains only ~1 Mb of euchromatin (Adams et 
al., 2000). The genomic DNA sequence of Drosophila is combined with all the known 
knowledge of Drosophila genetics and function in a publicly available database, called 
FlyBase (dos Santos et al., 2014). Although “Drosophila” is typically used to refer to 
Drosophila melanogaster, and indeed this is the case throughout this work, there are 
actually over 1500 different species in the Drosophila genus of the Drosophilidae family, 
of which 12 have been sequenced (Bächli, TaxoDros website; Drosophila 12 Genomes 
Consortium, 2007).  
 Gene Expression in Drosophila 1.6
The development of the larval anterior to posterior (A-P), or head to tail, axis has been 
the subject of intensive research. The process of the segmentation and organization of the 
body plan resulting in the formation of distinct developmental identities is proposed to be 
controlled by a regulatory hierarchy of five sets of genes: maternal effect genes, gap 
genes, pair rule genes, segment polarity genes, and homeotic genes (Figure 5). Most of 
these genes encode transcription factors. Segmentation begins before the egg is laid 
during oogenesis of the mother. In the ovary of the mother, specific genes are transcribed 
and their transcripts are transported to the egg and function after fertilization to pattern 
the embryo and specify cell states (St Johnston & Nüsslein-Volhard, 1992). For example, 
Bicoid RNA is localized in the cytoplasm at the anterior pole of the egg and is translated 
after fertilization to produce an A-P concentration gradient of Bicoid protein. A mother 





segments are missing (Driever & Nüsslein-Volhard, 1988).  Maternal effect proteins 
 
Figure 4. Mitotic Chromosomes of Drosophila, Showing Euchromatic Regions, 
Heterochromatic Regions, and Centromeres. 
Arms of the autosomes are designated 2L, 2R, 3L, 3R, and 4. Length is in megabases 
(Mb). The heterochromatic block of the X chromosome is polymorphic among stocks and 
varies from one-third to one-half of the length of the mitotic chromosome. The Y 
chromosome is nearly entirely heterochromatic (Adams et al., 2000. Reprinted with 







Figure 5. Segmentation Genes are Expressed as a Hierarchy to Regulate the Pattern 
of Development Along the A-P axis of a Developing Drosophila Embryo. 
These are in situ hybridizations to mRNA of representative genes from each class of 
segmentation gene in the segmental hierarchy. The protein products of genes expressed 
earlier in the hierarchy regulate the expression of genes further down in the hierarchy to 
segment the developing embryo and determine segmental identities. The expression 
patterns of the Maternal coordinate gene, bicoid (bcd), Gap gene, Krüppel (Kr), Pair rule 
gene, runt (run), Segmental polarity gene, engrailed (en), and Homeotic selector genes, 







regulate the expression of the second class of segmentation genes, the gap genes. Gap 
genes are amongst the first zygotically expressed genes and are transcribed in spatially 
restricted expression domains along the A-P axis of the embryo and include: huckebein, 
tailless, giant, hunchback, Krüppel, and knirps  (St Johnston & Nüsslein-Volhard, 1992). 
Gap loss-of-function (lf) mutations result in the loss of multiple, contiguous segments. 
The gap proteins regulate the expression of the third class of segmentation genes, the pair 
rule genes. Pair rule genes are expressed in a pattern of seven repetitive stripes (Rivera-
Pomar & Jãckle, 1996). In homozygous pair rule mutants,  every other segment is deleted 
(Jürgens et al., 1984; Wakimoto & Kaufman, 1981). The expression pattern of pair rule 
genes establishes 14 parasegments. Subsequently, the pair rule proteins regulate the 
expression of segment polarity genes. Segment polarity genes establish the polarity 
within a segment. Segment polarity mutations cause posterior cells to form anterior 
structures, often producing a mirror image of the anterior region (Nüsslein-Volhard & 
Wieschaus, 1980). The expression of the segment polarity genes, wingless and engrailed, 
define the parasegmental boundaries. 
 
After the body is segmented by the first four classes of genes, the expression of the fifth 
class, Hox genes, determines the unique structure of individual body segments, referred 
to as segmental identity. Hox genes are important regulatory genes that are expressed in 
spatially restricted domains along the A-P axis of the embryo by the segmentation genes 
(Ingham & Martinez Arias, 1992). For example, the Hox gene, Dfd is expressed in the 
maxillary segment near the anterior end of the embryo, while the Hox gene, Abd-B is 
expressed in the most posterior end of the embryo in abdominal segments 8 and 9 (Figure 
5). The phenotype of lf and gain-of-function alleles in Hox genes are the homeotic 
transformations of one segment into the likeness of another (Bateson, 1894; Bridges, 
1915).  
 The Homeotic Selector (or Hox) Genes  1.7
The order of the Homeotic, or Hox genes along the chromosome coincides with the 
relative position of their expression pattern along the A-P axis of a developing embryo. 





which is expressed most anteriorly in the embryo, and the right most gene, AbdB, is 
expressed most posteriorly in the embryo. All of the intervening genes along the 
complex, proboscipedia (pb), Dfd, Sex combs reduced (Scr), Antennapedia (Antp), 
Ultrabithorax (Ubx), and abdominal-A (abdA), are expressed appropriately along the A-P 
pattern in the embryo according to their position in the complex (Figure 6). This pattern 
of expression is referred to as collinearity. The collective composition of the Hox gene 
complex is referred to as the homeotic complex (HOM-C). The HOM-C complex is 
broken into two in Drosophila, the Antennapedia and the Bithorax complexes (ANT-C 
and BX-C).  
The Hox genes contain a homeobox that encodes a DNA-binding motif, called a 
homeodomain. The HOX proteins are transcription factors and the homeodomain 
recognizes and binds to specific sequences of DNA (Levine & Hoey, 1988).  Hox mutant 
alleles result in homeosis, in which the morphology of a body region is transformed to 
that of a different region (Bateson, 1894). Therefore, Hox genes act as binary switches, 
where loss of function produces one transformation in the region where the gene is active 
and gain of function produces the opposite transformation where the gene is normally 
inactive. For example, the antenna and leg are homologous appendages and mutations 
can cause the transformation of one into the other (Postlethwait & Schneiderman, 1971; 
Struhl, 1982). The appendages are homologous in that the different parts correlate to 
similar positions along the proximal-distal axis (Figure 7). The first antennal segment is 
homologous to the leg coxa, where they join to the body of the fly. The second antennal 
segment is homologous to the trochanter of the leg. The third antennal segment is 
homologous to the femur, tibia, and first tarsal segment of the leg and the arista and its 
base are homologous to the distal tarsal segments including the tarsal claw (Postlethwait 
& Schneiderman, 1971).  
One of the major findings in developmental biology is that Hox genes are conserved at 
four levels: structure, expression, requirement, and function. The structure of individual 
Hox genes is conserved as well as the structure of the Hox gene complexes (Graham et 
al., 1989). The collinear pattern of expression of Hox genes is conserved (Graham et al., 






Figure 6. Hox Genes in Drosophila. 
The order in which the Hox genes appear A-P in the complex on the chromosome 
correspond to the domain of expression along the A-P axis of the embryo and the 
segmental identity of A-P body parts in the adult fly. Abbreviations: HOM-C, Homeotic 
complex; ANT-C, Antennapedia complex; BX-C, Bithorax complex; lab, labial; pb, 
proboscipedia; Dfd, Deformed; Scr, Sex combs reduced; Antp, Antennapedia; Ubx, 
Ultrabithorax; abdA, abdominal-A; AbdB, Abdominal-B. This figure was adapted from 






Figure 7. Homologous Appendages: Insect Leg and Antenna. 
The first antennal segment is homologous to the leg coxa, where they join to the body of 
the fly. The second antennal segment is homologous to the trochanter of the leg. The 
third antennal segment is homologous to the femur, tibia, and first tarsal segment of the 
leg and the arista and its base are homologous to the distal tarsal segments including the 







development of body plans of bilaterally symmetric organisms. Finally, a Hox gene of 
one organism can functionally replace that of another organism. These levels of Hox 
conservation are generally well established at a level of similarity; however, this work 
examines conservation of requirement in insects at a more detailed level of whether they 
are the same. 
 The Homeotic Transcription Factors, Scr, Antp, and Ubx 1.8
This project attempts to examine the requirement of a specific set of Hox genes 
potentially involved in tarsus determination. These Hox genes are, Sex combs reduced 
(Scr), Antennapedia (Antp), and Ultrabithorax (Ubx), which have an integral role in 
thorax development (Struhl, 1982). Scr activity is required for the prothorax (the first 
thoracic segment, T1) and Ubx activity is required for the metathorax (third thoracic 
segment, T3; Struhl, 1982). When these two genes are absent, both segments develop like 
the mesothorax (the second thoracic segment, T2; Struhl, 1982). If Ubx is lost early in 
development, while Scr remains, then posterior portions of the mesothorax and the 
metathorax develop as in the prothorax (Kerridge & Morata, 1982; Morata & Kerridge, 
1981). All three thoracic segments require Antp activity and when it is absent, part of the 
mesothorax is transformed into corresponding antennal structures (Figure 8; Struhl, 
1981b, 1982). Similar transformations to antenna occur in the prothorax and metathorax 
when Scr and Ubx are absent as well (Struhl, 1982). When examining normal HOX 
protein expression patterns early on in development, both ANTP and SCR are expressed 
in all leg imaginal discs. Specifically, ANTP is expressed in the ectoderm and by the late 
3
rd
 larval stage , ANTP is not expressed in the tarsus primordium (Wirz et al., 1986), but 
is restricted to the proximal leg primordium to help determine proximal leg structures 
(Abu-Shaar & Mann, 1998; Casares & Mann, 2001; Emerald & Cohen, 2004). SCR is 
expressed in the mesoderm of all leg imaginal discs (Glicksman & Brower, 1988). UBX 
is expressed strongly in the ectoderm of the third thoracic leg, and weakly in the second 
thoracic leg (Brower, 1987).  
The analysis of orthologs in other species that evolved from a common ancestor can be 






Figure 8. Phenotype of Somatic Clones Lacking the Antp Gene in the Drosophila 
Second Leg. 
(A) Wild-type, second leg. (B) A blastoderm Antp clone covering the entire anterior 
compartment of the second leg, transforms it into corresponding portions of the antenna. 
Note the presence of structures characteristic of the first (I), second (II) and third (III) 
antennal segments. Note also that marked cells situated at the margins of the clone form 
normal leg tissue (in this case, a claw (arrow) and bristles characteristic of the distal leg). 
The untransformed posterior compartment lies beneath the transformed anterior 






extensively studied in Drosophila, Hox genes have been studied at length in the closely 
related insect, Tribolium casteneum, red flour beetle, which both diverged from a 
common ancestor around 300 million years ago. In Tribolium, the Scr ortholog, 
Cephalothorax, is required for normal development of the first thoracic segment (T1) 
(Beeman et al., 1993), and the Ubx ortholog, Ultrathorax,  is required for the normal 
development of T3 (Beeman et al., 1989), as found in Drosophila (Figure 9.A). However, 
the beetle Antp ortholog, prothoraxless (ptl) may not be required in the same manner as 
in Drosophila. In Tribolium, lf ptl mutant alleles result in transformations of all three 
thoracic legs to antennae (Figure 9.B&C; Beeman et al., 1993). In Drosophila, Antp
lf 
alleles affect the development of the proximal leg only resulting in a leg to third antennal 
segment transformation and do not result in a tarsus to arista transformation of the distal 
leg as observed in Tribolium (Figure 8; Struhl, 1981). Unfortunately, this analysis of Antp 
function in adult Drosophila was performed using mosaic analysis where only small 
clones of Antp
lf 
tissue were generated and analyzed in an otherwise wild type leg 
(Percival-Smith et al., 2005; Struhl, 1981b). In addition, tarsus determination is a non-cell 
autonomous process, which would not allow the identification of a tarsus to arista 
transformation in the leg of an Antp lf/+ mosaic, even if Antp is required for tarsus 
determination (Percival-Smith et al., 2005; Struhl, 1981). Furthermore, when the HOX 
proteins, SCR, ANTP, and UBX, as well as the other Drosophila HOX proteins 
excluding PB, are ectopically expressed in the antenna, an arista to tarsus transformation 
is induced, such that the HOX protein required for tarsus determination in Drosophila is 
unknown (Abbott & Kaufman, 1986; Burgess & Duncan, 1990; Casares et al., 1996; 
Emerald & Cohen, 2004; Gibson & Gehring, 1988; Gibson et al., 1990; Mann & 
Hogness, 1990; Percival-Smith et al., 2005; Percival-Smith et al., 1997; Schneuwly et al., 
1987; Struhl, 1981b, 1982). 
 Nanobodies 1.9
A novel method has recently been developed to selectively target and knock down 
proteins. In 1993, it was discovered that the immune systems of Camelidae (i.e. camels 
and llamas) contain functional antibodies that are composed of heavy polypeptide chains 






Figure 9. (Left) The Hox Genes in Drosophila and Tribolium. (Right) Terminal 
Phenotype of Lethal ptl lf Mutation in Tribolium. 
(A) The regions of the A-P axis affected by lf mutations in Drosophila and Tribolium 
Hox genes are indicated by lines, with pb and extra urogomphi (eu) being dotted to 
indicate that they do not affect embryos. Segment abbreviations: ant, antennal; int, 
intercalary; mn, mandibular; mx, maxillary; la, labial; T, thoracic; A, abdominal. (B) 
Lateral view of head (H) through T2 of wild-type first instar larva. (C) Lateral view of 
head through A2 of a first instar ptl
D6O
 homozygote. Note transformation of all three pairs 
of thoracic legs into antennae. Abbreviations: lb, labial palps; an, antennae; mn, 






IgG) are all comprised of a similar basic structural unit of two identical heavy 
polypeptide chains and two identical light polypeptide chains which are linked together 
by disulphide bridges to form two antigen-binding (Fab) regions that are linked to a 
constant (Fc) region via a flexible hinge (Figure 10; Woof & Burton, 2004) . The amino 
terminal variable domains of the two Fab regions of the antibody mediate the highly 
specific recognition of the antigen target (epitope). IgG of Camelidae species differ from 
conventional antibodies as antigen binding is achieved by a single heavy chain variable 
domain (VHH; Figure 10). The VHH domain represents the smallest (only 15 kDa) 
available intact antigen-binding fragment, referred to as a nanobody (Muyldermans, 
2001). This is half the size of the smallest intact antigen-binding fragment that can be 
generated from conventional antibodies, and has the potential to allow access to epitopes 
that are not reached by conventional antibodies (Muyldermans, 2001). Interestingly, in 
1995 a research team at the University of Miami found a similar type of heavy-chain only 
antibody in sharks and other cartilaginous fish (termed VNAR; Greenberg et al., 1995). 
The VHH is able to bind to targets with high affinity and specificity because of a long 
complementarity determining region 3 (CDR3) loop, which enlarges the surface area of 
the antigen binding site of the VHH (Arbabi Ghahroudi et al., 1997). Compared to 
antigen-binding derivatives of conventional antibodies, the single domain nature of VHH 
gives rise to several unique features and advantages. First, the antigen recognition is 
encoded by a single polypeptide in a single gene, which allows easy design of systems for 
the selection of antigens with a particular epitope. Second, VHHs are naturally robust, 
highly soluble and stable. Their solubility is greatly improved over that of other 
antibodies due to substitutions of hydrophobic by hydrophilic residues within the VHH 
folded domains (Muyldermans, 2001).  Finally, the close homology of the VHH fragment 
to human VH fragments is of great diagnostic and therapeutic value (Muyldermans, 2001). 
Presently, mouse therapeutic antibodies can elicit an immune response in the human 
patient, whereas nanobodies are less likely to do so (Courtenay-Luck et al., 1986; 
Muyldermans, 2001). 
To isolate a specific VHH domain that recognizes GFP, an alpaca (Lama pacos) was 






Figure 10. Conventional Immunoglobulins Versus Camelidae Species 
Immunoglobulins. 
Conventional antibodies (or immunoglobulins, IgG) are composed of two identical heavy 
chains and two identical light chains, linked by disulphide bridges (Fab), which are 
connected by a flexible hinge to constant (Fc) domains. Light chains fold into a variable 
domain (VL) and a constant domain (CL), whereas heavy chains are composed of one 
variable domain (VH) and multiple constant domains (CH). The variable domains of both 
the heavy and light chains at the tip of the Fab form the antigen-binding sites. IgG of 
Camelidae species differ in antigen binding is achieved by a single heavy chain variable 







binding antibody fragment, α-GFP VHH (GFP-nanobody), was identified (Rothbauer et 
al., 2006).  The GFP-nanobody has the ability to precipitate its antigen from cell extracts 
more efficiently than mono- and polyclonal anti-GFP antibodies (Rothbauer et al., 2008). 
Furthermore, GFP remains stably bound to the GFP-nanobody even under high salt 
conditions, high temperature conditions, and between the range of pH 4 to pH 11 
(Rothbauer et al., 2008). The structure of the GFP:GFP-nanobody complex formation 
was determined  using X-ray crystallography to determine the criteria of specificity for 
recognition of fluorescent proteins (Figure 11; Kubala et al., 2010). The GFP-nanobody 
can also bind to the yellow fluorescent protein (YFP), and a modified cyan fluorescent 
protein (CFP; Kubala et al., 2010). Therefore, GFP, YFP, and a modified CFP can be 
used in conjunction with the GFP-nanobody (Kubala et al., 2010). This is especially 
useful since GFP, CFP, and YFP fluorescence can be visualized separately when they are 
co-expressed. This technology has been used  in vitro, in vivo, and in planta (Rothbauer 
et al., 2008, 2006; Schornack et al., 2009). Additionally, the 17 amino acids 
(ILGHKLEYNYNSHNVYI) spanning the epitope on GFP that is recognized by the GFP-
nanobody is a sufficient, small target for binding (Grallert et al., 2013).  
Caussinus et al. (2012) engineered a method to knock out GFP fusion proteins in any 
eukaryotic genetic system using the endogenous ubiquitin pathway. The ubiquitin 
pathway is an integral component of selective protein degradation in eukaryotes. Target 
proteins that acquire multiple ubiquitin molecules, which are covalently attached through 
a complex cascade of enzymes, are subsequently degraded by the proteasome 
(Ciechanover, 1998). Substrate specificity in the ubiquitin pathway is determined by F-
box proteins (FBP). FBPs are modular with two distinct domains:  An F-box domain that 
interacts with the ubiquitin pathway and a protein-protein interaction domain (such as 
WD40 repeats) on the C-terminus which binds to a specific substrate (Zhang et al., 2003).  
Supernumerary limbs (Slmb) is a Drosophila FBP involved in normal growth and 
patterning during development (Jiang & Struhl, 1998). A new FBP, NSlmb-vhhGFP4, 
was engineered by fusing the F-box domain contained in the N-terminal part of Slmb to 
the GFP-nanobody (vhhGFP4), which permits target proteins fused to GFP (or relevant 






Figure 11. Structure of the Complex Formed When the GFP-nanobody is Bound to 
GFP. 
Ribbon diagram (based on X-ray crystallography) showing perpendicular views of the 
GFP:GFP-nanobody complex. GFP is shown in green to gold and the GFP-nanobody 






(Figure 12; Caussinus et al., 2012). Additionally, since the target protein is fused to a 
fluorescence protein, the removal of the target protein can be easily monitored. To 
determine the kinetics of target protein degradation by NSlmb-vhhGFP4, live imaging of 
Drosophila embryos was used to monitor the decrease in nuclear fluorescence of a target 
protein signal relative to the appearance of another nuclear fluorescence that served as the 
NSlmb-vhhGFP4 expression reporter (Figure 13; Caussinus et al., 2012). The 
accumulated target protein begins to disappear from the embryos less than 30 min after 
expression of NSlmb-vhhGFP4 and is reduced to 10% of its maximum intensity in less 
than 3 hours (Caussinus et al., 2012). Transgenic Drosophila lines in which targeted 
NSlmb-vhhGFP4 expression can be achieved with the UAS-GAL4 system, have already 
been generated (Caussinus et al., 2012). This technique allows the dissection of 
morphogenetic forces in a cell- and tissue-specific manner and allows fast tissue-specific 
knockouts which were previously not feasible in post-mitotic cells (Caussinus et al., 
2012). 
 Goal 1.10
My goal is to address the question of what HOX protein is required for tarsus 
determination in Drosophila. To answer this question, a method is required that inhibits 
HOX activity only during larval stages and not during embryogenesis as HOX activity is 
essential for the development of viable larvae (Brown et al., 2002). Additionally, the 
method needs to inhibit HOX activity in all cells of the larva such that no hypothetical 
HOX-dependent cell signalling molecule is produced. I propose to use a heat shock-
inducible nanobody (UAS- NSlmb-vhhGFP4 driven by hsp-GAL4) activated during the 
third larval stage in all cells to degrade thoracically expressed HOX proteins (SCR, 
ANTP, and UBX) tagged with XFP (GFP derivatives; GFP, YFP, CFP, or 17 amino acid 
(aa) epitope of GFP; Figure 14).  I will use the GFP-nanobody degrader (nanobody) to 
determine whether the requirement for ANTP matches that of the requirement for Ptl in 
Tribolium. This would suggest that requirement is conserved in insects. If the 
requirement is not conserved, then tarsi may be determined by SCR alone, or in 
conjunction with other HOX proteins, suggesting that HOX requirement for tarsus 






Figure 12. Schematic Illustration of GFP-nanobody Degrader. 
(A) Linear representation of Slmb, and NSlmb-vhhGFP4. Numbers refer to amino acid 
positions from N terminus (N) to C terminus (C). (B) SKP1–CUL1–F-box protein ligase 
complexes (SCFs) mediate the ubiquitin transfer from E2 enzymes to target substrates. 
Ubiquitin-tagged substrates are then degraded by the proteasome. The specificity of the 
SCFs depends on the FBPs, which are either endogenous like Slmb or engineered like 







Figure 13. Kinetics of Target Protein Degradation by GFP-nanobody Degrader in 
Drosophila. 
Live confocal imaging of embryos in stages 9 to 13 was used to show the degradation of 
a target protein (His2Av::EYFP; green) compared to expression of an NSlmb-vhhGFP4 
reporter (mCherry-NLS; purple). The data points measured in the embryo are represented 
(crosses) and summarized by regression curves (continuous and dashed lines). The data is 
normalized and aligned in time with respect to mCherry-NLS expression and maturation 
(vertical dashed line is time t). On average, the His2Av::EYFP signal is reduced to 10% 








Figure 14. Model: Nanobody Expression to Target and Degrade XFP-tagged 
Proteins. 
A heat-shock promoter (hsp) activated at the third larval stage of Drosophila 
development induces expression of the transcriptional activator, GAL4. This GAL4 driver 
line induces the GAL4 responsive promoter, or upstream activation sequence (UAS). UAS 
activation causes expression of the GFP-nanobody degrader (“nanobody”), which then 
targets GFP derivatives (XFP; tag) for poly-ubiquitination. Consequently, HOX fusion 








UBX are not required for tarsus determination in Drosophila, then the mechanism of 







2 Materials and Methods 
 Plasmids 2.1
Table 1 documents the origin of the plasmids used in this study. 
 Drosophila Strains 2.2
Drosophila were maintained at 25ºC with 60-65 % relative humidity on standard 
Drosophila media supplemented with baker’s yeast ("Media Recipes and Methods", 
Bloomington Drosopila Stock Center website). Table 2 documents the genotype and 
origin of the fly strains used in this study.   
 chiRNA for CRISPR-mediated HR 2.3
chiRNA specific for Scr, Antp, and Ubx coding regions were designed to target a DSB as 
close to the stop codon as possible (“Protocols: U6-gRNA (chiRNA) cloning", 
flyCRISPR website). Primers phosphorylated at the 5’ end were designed to encode the 
20 nt corresponding to the target sequence (Appendix B.a). The forward and reverse 
primers were annealed together, and the double stranded product was ligated (T4 DNA 
Ligase – Invitrogen) into the pU6-BbsI-chiRNA vector that had been digested with BbsI. 
The ligation reaction was used to transform Escherichia coli Subcloning Efficiency™ 
DH5™ Competent Cells (Invitrogen) and ampicillin resistance was selected for on LB 
agar plates. The plasmid DNA was isolated (Geneaid miniplasmid prep kit) and digested 
with the restriction enzyme BbsI. Selected plasmid clones that had lost the BbsI 
recognition site (i.e. did not get cleaved) were sent for sequence analysis (Robarts 
Research Institute DNA Sequencing Facility). 
 Repair Vectors for CRISPR-mediated HR 2.4
The donor templates for HR were designed to consist of: 5’Hox::(XFP or tag) loxP 
y
+
loxP 3’Hox inserted in a pFUS_A plasmid (Figure 15.B). The following are the six 
repair vectors constructed: 5’Scr::GFP loxP y+loxP 3’Scr, 5’Scr::tag loxP y+loxP 3’Scr, 
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Table 1. Origin of Plasmids. 
Plasmid names, supplier, reference, and purpose for use in this work, as well as indication 
of whether an appendix exists are given. Legend: N/A, not applicable; APS, Dr. Anthony 








Stock Genotype Origin Reference Short 
Form 
y w Df(1)w[67c23.2]  APS lab N/A y w 
496 y w ; L / CyO ; TM6B, Tb, 
P{walLy} / Ki ftz[11] 
APS lab N/A balancer 
805 y w ; P{arm-GAL4, w+} ; 
TM6B, Tb, P{walLy} / 
Scr[14] e 
APS lab Sivanantharajah, 
L. & Percival-
Smith, A. (2014) 
armGAL4 
2077 w ; P{GAL4-Hsp70.PB}2 Bloomington 
Stock Centre 
Tenney, K. et al. 
(2006) 
GAL4(hs) 
7108 w ; P{tubP-GAL80[ts]}10 ; 
TM2 / TM6B, Tb 
Bloomington 
Stock Centre 
McGuire, S. E. 
et al. (2003) 
GAL80(ts) 
7019 w ; P{tubP-GAL80[ts]}20 ; 
TM2 / TM6B, Tb 
Bloomington 
Stock Centre 
McGuire, S. E. 
et al. (2003) 
GAL80(ts) 











Port, F. et al. 
(2014) 
act-Cas9 
54591 y M{nos-Cas9.P}ZH-2A w Bloomington 
Stock Centre 
Port, F. et al. 
(2014) 
nos-Cas9 
Table 2. Genotypes and Origins of Fly Stocks. 
Abbreviations: Df, deficiency; y, yellow; w, white; P{}, P element transposon; arm, 
armadillo; TM6b, balancer of chromosome 3; Tb, Tubby; walLy, fragment containing y+ 
gene; Ki, Kinked; ftz, fushi-tarazu; Hsp, heat-shock promoter; tubP, tubulin promoter; ts, 
temperature sensitive; TM2, balancer of chromosome 3; UAS, upstream activation 
sequence; Nslmb-vhhGFP4, GFP-nanobody degrader, L, Lobe; CyO, Curly; Scr, Sex 
combs reduced; e, ebony; nos, nanos promoter; act5C, actin5C promoter; N/A, not 










Figure 15. General Design of Repair Vectors. 
(A) The 5’Hox::XFP or 5’Hox::tag (DNA fragment 1), loxP y+ (DNA fragment 2) and 
loxP 3’Hox (DNA fragment 3) fragments are all created by standard PCR with unique 
cohesive ends when digested with the restriction endonuclease, BsaI. The pFUS_A vector 
is digested with BsaI and dephosphorylated. (B) All four DNA fragments ligate together 
in a single ligation reaction to form a circularized repair vector for use in injecting 







5’Ubx::YFP loxP y+loxP 3’Ubx, and 5’Ubx::tag loxP y+loxP 3’Ubx  (annotated sequence 
in Appendix A.d). The pFUS_A vector was digested with BsaI and dephosphorylated.  
For each of the six constructs, three DNA fragments were created using standard PCR 
mutagenesis technique (McPherson & Møller, 2000) with a Platinum® Taq DNA 
Polymerase High Fidelity (Invitrogen). The following thermocycling parameters were 
generally used: 94ºC for 2 min; 30 cycles of 94ºC for 45 s, 58ºC for 45 s and 72ºC for 20 
min; 72ºC for 10 min; and held at 4ºC. Primers used for amplification are included in 
Appendix B. 
DNA fragment 1 contains the 5’ portion of a Hox gene fused either to XFP (GFP, YFP, 
or CFP) or a tag (Table 3) and was created in two steps (Figure 15.A).  First, genomic 
DNA was isolated from adult y w flies.  The 5’Scr, 5’Antp, and 5’Ubx portions were 
amplified with the reverse primers containing identical sequence to GFP or the tag (An 
illustrative example is given in Figure 16) 
Second, a series of products were created with identical sequence to 5’Scr, 5’Antp, and 
5’Ubx.  
A pEGFP plasmid was used to amplify GFP with a forward primer containing identical 
sequence to 5’Scr (Figure 16). 
The pEGFP plasmid was also used to amplify a modified CFP with a forward primer 
containing identical sequence to 5’Antp. In addition, primers were used containing 
sequence changes to alter aa positions 66, 153, and 163 to create a CFP from the GFP 
sequence that is recognized by the nanobody. The GFP aa 66 position was changed from 
Tyr (DNA sequence TAC) to Trp (TGG). The GFP aa 153 position was changed from 
Met (ATG) to Thr (ACC). The GFP aa 163 position was changed from Val (GTG) to Ala 
(GCA). 
A pFA6a-EYFP-natMX6 plasmid was used to amplify YFP with a forward primer 
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Table 3. Protein and DNA Sequence of the Tag Fused to 5’ Hox Genes. 
The tag consists of a fusion of the 17 aa epitope on GFP (17aa) that is recognized by the 







Figure 16. Schematic Example of Generating DNA Fragment 1. 
DNA source is indicated above and arrows indicate position and orientation of primers 
used to PCR each DNA fragment resulting in 5’Scr::GFP and 5’Scr::tag. “tag” refers to a 





To fuse 5’ Scr to GFP; the isolated product, 5’Scr containing identical sequence to GFP, 
was used in a reaction with the isolated product, GFP with identical sequence to 5’Scr 
(Figure 16). 
To fuse 5’ Antp to CFP; the isolated product, 5’Antp containing identical sequence to 
GFP, was used in a reaction with the isolated product, CFP with identical sequence to 
5’Antp. 
To fuse 5’ Ubx to YFP; the isolated product, 5’Ubx containing identical sequence to 
GFP, was used in a reaction with the isolated product, YFP with identical sequence to 
5’Ubx. 
The pEGFP plasmid was used to amplify the 17 aa epitope of GFP that is recognized by 
the nanobody (ILGHKLEYNYNSHNVYI) with a forward primer containing identical 
sequence to 5’Scr, 5’Antp, and 5’Ubx and a reverse primer containing identical sequence 
to a 3X FLAG peptide. The product was used in a subsequent reaction with the 
following: A pUBXTT plasmid was used to amplify a 3X FLAG peptide with a forward 
primer containing identical sequence to the 17 aa epitope of GFP 
(ILGHKLEYNYNSHNVYI). The resulting product was an amplified fragment of 17 aa 
epitope of GFP (17aa) fused with the 3X FLAG peptide (collectively called “tag”) with a 
forward primer containing identical sequence to 5’Scr, 5’Antp, and 5’Ubx (An illustrative 
example is given in Figure 16) 
To fuse 5’ Scr to tag; the isolated product, 5’Scr containing identical sequence to tag, was 
used in a reaction with the isolated product, tag with identical sequence to 5’Scr (Figure 
16). 
To fuse 5’ Antp to tag; the isolated product, 5’Antp containing identical sequence to tag, 
was used in a reaction with the isolated product, tag with identical sequence to 5’Antp. 
To fuse 5’ Ubx to tag; the isolated product, 5’Ubx containing identical sequence to tag, 





DNA fragment 2 contains either the loxP or lox 2272 site fused to the y+ gene (Figure 
15.A).  A minos-mediated integration cassette (MiMIC; GenBank accession code 
GU370067) vector was digested, and used as the template for amplification of yellow+ 
with forward primers that incorporated on the 5’ end a loxP site or a lox2272 site.  
DNA fragment 3 contains a loxP fused to the 3’ of Scr and Ubx or a lox2272 site fused to 
the 3’ of Antp (Figure 15.A).  Genomic y w DNA was used to create 3’Antp, 3’Scr, and 
3’Ubx portions with primers that incorporated on the 5’ end a loxP site for 3’Scr and 
3’Ubx and a lox2272 site for 3’Antp.   
The products were verified by 1% (w/v) agarose gel electrophoresis, which was stained 
with RedSafe (FroggaBio), and visualized on a gel doc (FlourChem8900 - Alpha 
Innotech). They were subsequently purified using a PCR Product purification kit 
(BioBasic Inc). The primers used to create all three DNA fragments contained the 
restriction endonuclease site, BsaI, which is a restriction enzyme that recognizes a six 
base sequence but generates a 4 base 5’ overhang outside the recognition site (Figure 
17.A). In the design, all eight 5’ overhangs of pFUS_A and the three DNA fragments had 
unique but complementary sequences such that the fragments would assemble in order 
during ligation (Figure 17.B).  The three DNA fragments were digested with BsaI and 
used in a ligation reaction (T4 DNA Ligase – Invitrogen) with the digested and 
dephosphorylated pFUS_A.  E. coli Subcloning Efficiency™ DH5™ Competent Cells 
(Invitrogen) were transformed and spectinomycin/streptomycin resistance was selected 
for on X-gal and IPTG containing LB agar plates.  When the fragments insert into 
pFUS_A , the lacZ gene is lost and therefore white colonies, but not blue colonies of 
bacteria, were chosen for PCR screening. The first PCR screen amplified a product from 
the 5’ end of pFUS_A to the 5’ end of the y+ marker gene. The second PCR screen 
amplified a product from the 3’ end of y+ to the 5’ end of pFUS_A. Primers used for 
screening are included in Appendix B. If a sample showed products for both screens, the 
plasmid DNA was isolated (Geneaid miniplasmid prep kit). The DNA was digested with 
selected restriction enzymes BamHI, BglII, HincII, Tth111, XbaI, XhoI, and XmnI. The 






Figure 17. Schematic of Using BsaI Unique Ends for a Single Ligation Reaction of 
the Repair Vectors.  
(A) The primers used to create all three DNA fragments contained the restriction 
endonuclease site, BsaI, which is a restriction enzyme that recognizes a six base sequence 
but generates a 4 base 5’ overhang outside the recognition site. (B) After being digested 
with BsaI, all eight 5’ overhangs of pFUS_A and the three DNA fragments had unique 








enzymes were isolated (QIAGEN QIAfilter midiprep kit). The six repair vectors were 
given the short forms: Scr::GFP, Scr::tag, Antp::CFP, Antp::tag, Ubx::YFP, and Ubx::tag. 
 CRISPR Germline Transformant Flies 2.5
2.5.1 Injections 
Drosophila embryos were injected using standard protocols (Murphy & Carter, 1993). 
Drosophila eggs were collected on apple or grape juice agar plates smeared with yeast 
paste. 3% bleach was used to dechorionate the embryos on the plates and the embryos 
were collected in mesh covered baskets. Embryos were then transferred to agar strips and 
lined up so they were all in the same orientation before getting transferred to double-
sided tape on a microscope slide. The embryos were placed under a dryer for 4 min and 
40 sec before covering the embryos with halocarbon oil. The slide was positioned on an 
inverted microscope equipped with a micromanipulator, micropipette holder, and a 
microinjector.  Syncytial blastoderm embryos expressing or not expressing Cas9 were 
injected with DNA (in a 10% Glycerol and 1X PBS solution) at the posterior end with a 
glass capillary injection needle (Table 4). The injected embryos on the tape were 
transferred to apple juice agar plates and kept at 18ºC for 48 hours before being allowed 
to hatch into larva and then eclose as adults in vials.  
To assess germline transmission of targeted genome modifications, G0 adults that 
developed from injected embryos were individually crossed to y w flies. The G1 offspring 
of crosses were screened for the phenotype of the marker used, w+ or y+.  The number of 
vials that produced no offspring (i.e. were sterile) were recorded along with the total. 
2.5.2 Verification of Injected Germline Transformant 
A transformant fly candidate was tested to confirm its genotype of Antp::CFP. A G0 adult 
injected fly was completely y+, indicating the presence of y+ locus in its genome. 
Genomic DNA was isolated from the y+ flies. 
To test for the presence of Antp::CFP at the Antp locus, PCR amplification of DNA 
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Table 4. Injected Flies and DNA. 






5’Antp only as a positive control (659 bp). The second product spans 5’Antp to the 
middle of CFP (848 bp). The third product spans 5’Antp to the 3’ end of CFP (1352 bp). 
Genomic y w DNA and genomic y w DNA spiked with Antp::CFP repair template DNA, 
were compared to the y+ genomic DNA using standard PCR mutagenesis technique 
(McPherson & Møller, 2000) with a Platinum® Taq DNA Polymerase High Fidelity 
(Invitrogen). The following thermocycling parameters were used: 94ºC for 2 min; 30 
cycles of 94ºC for 45 s, 58ºC for 45 s and 72ºC for 20 min; 72ºC for 10 min; and held at 
4ºC. Primers used for amplification are included in Appendix B. 
The candidate Antp::CFP flies were crossed with fly line 496 (containing balancer 
chromosomes) to analyze the segregation pattern of Lobe, Curly, Tubby, and y+ to 
determine whether the y+ locus is on the 2
nd
 or the 3rd chromosome, which contains the 
Antp locus. 
 Crossing Schemes 2.6
The goal is to create flies with the genotype for nanobody degradation of HOX::XFP 
proteins.  This genotype will be homozygous for the Hox::XFP locus/loci and have the 
genetic elements for GAL4-dependent expression of the nanobody. Expression of the 
nanobody will be regulated in one of two ways: first by using an hsp-GAL4 fusion gene 
for heat shock-induced GAL4 expression, and second a ubiquitously expressed GAL4 
source, arm-GAL4, that is silenced by expression of a temperature sensitive (ts) GAL80 
from a ubiquitously expressed tubP-GAL80
ts
 transgene.  GAL80
ts
 activity is inhibited at 
30ºC, allowing expression of the nanobody. Each fly line was made homozygous with 
standard crosses (Greenspan, 2004). 
The following short forms are used in the crossing schemes: GAL4(hs),  GAL4-Hsp70; 
armGAL4, arm-GAL4; UAS-nano, UAS-Nslmb-vhhGFP4; and GAL80+UAS-nano, 
tubP-GAL80[ts], UAS-Nslmb-vhhGFP4.  
Below are the four separate crossing schemes to result in two final genotypes: 
y w ; P{GAL4-Hsp70.PB}2 / P{UAS-Nslmb-vhhGFP4}2 ; Hox::XFP y
+
, referred to as the 





P{tubP-GAL80[ts]}, P{UAS-Nslmb-vhhGFP4}2 ; Hox::XFP y
+
, referred to as the 
homozygous Hox::XFP with armGAL4 and GAL80+UAS-nano.  
2.6.1 Crossing Scheme 1: GAL80+UAS-nano 
Crossing scheme 1 (Figure 18) is the recombination of the GAL80 source onto the same 
second chromosome as the UAS-nano source resulting in a stock homozygous for the 
GAL80 and UAS-nano and a balanced lethal third chromosome: 
y w* ; P{tubP-GAL80[ts]}, P{UAS-Nslmb-vhhGFP4}2 ; TM6, Tb, P{walLy} / Ki ftz
11
 
This stock is used in crossing scheme 3. 
2.6.2 Crossing Scheme 2: GAL4(hs) and UAS-nano 
Crossing scheme 2 (Figure 19) creates two balanced stocks. The GAL4(hs) stock is 
homozygous for GAL4(hs) on the 2
nd
 chromosome with a balanced 3
rd
 chromosome . The 
UAS-nano stock is homozygous for UAS-nano on the 2
nd
 chromosome with a balanced 
3
rd
 chromosome. They are, respectively:  
y w ; P{GAL4-Hsp70.PB}2 ; TM6B, Tb, P{walLy} / Ki ftz
11 
and 
y w ; P{UAS-Nslmb-vhhGFP4}2 ; TM6B, Tb, P{walLy} / Ki ftz
11
 
Both of these stocks are used in crossing scheme 3. 
2.6.3 Crossing Scheme 3: Heterozygous Hox::XFP with either 
GAL4(hs), UAS-nano, GAL80+UAS-nano, or armGAL4 
Crossing scheme 3 (Figure 20) creates balanced flies with either Scr::GFP, Scr::tag, 
Antp::CFP, Antp::tag, Ubx::YFP, or Ubx::tag and one nanobody component, GAL4(hs), 
UAS-nano, or GAL80+UAS-nano. The genotypes are: 
y w ; P{GAL4-Hsp70.PB}2 / L ; TM6B, Tb, P{walLy} / Hox::XFP y
+
 and 
y w ; P{UAS-Nslmb-vhhGFP4}2 / L ; TM6B, Tb, P{walLy} / Hox::XFP y
+
 and 
y w*; P{tubP-GAL80[ts]}, P{UAS-Nslmb-vhhGFP4}2 / L ; TM6B, Tb, P{walLy} /             
Hox::XFP y
+
 and  
y w ; P{arm-GAL4 w+} / L ; TM6B, Tb, P{walLy} / Hox::XFP y
+
 







Figure 18. Scheme to Create the GAL80+UAS-nano Genotype: 










Figure 19. Scheme to Create the GAL4(hs) Genotype and UAS-nano Genotype: 
GAL4(hs): y w ; P{GAL4-Hsp70.PB}2 ; TM6B, Tb, P{walLy} / Ki ftz
11
 









Figure 20. Scheme to Create the Heterozygous Hox::XFP with GAL4(hs), UAS-
nano, GAL80+UAS-nano, and armGAL4 (Respectively) Genotypes: 
y w ; P{GAL4-Hsp70.PB}2 / L ; TM6B, Tb, P{walLy} / Hox::XFP y
+
  
y w ; P{UAS-Nslmb-vhhGFP4}2 / L ; TM6B, Tb, P{walLy} / Hox::XFP y
+
  
y w*; P{tubP-GAL80[ts]}, P{UAS-Nslmb-vhhGFP4}2 / L ; TM6B, Tb, P{walLy} /     
    Hox::XFP y
+
  









2.6.4 Crossing Scheme 4: Homozygous Hox::XFP with GAL4(hs) 
and UAS-nano & Homozygous Hox::XFP with armGAL4 and 
GAL80+UAS-nano 
Crossing scheme 4 (Figure 21) creates the final flies that are homozygous at Hox::XFP 
locus/loci and carrying one of the two GAL4 sources and the UAS-nanobody source. The 
final genotypes are: 
y w ; P{GAL4-Hsp70.PB}2 / P{UAS-Nslmb-vhhGFP4}2 ; Hox::XFP y
+
 and 











Figure 21. Scheme to Create the Homozygous Hox::XFP with GAL4(hs) and UAS-
nano Genotype as well as the Homozygous Hox::XFP with armGAL4 and 
GAL80+UAS-nano Genotype: 
Homozygous Hox::XFP with GAL4(hs) and UAS-nano: 
y w ; P{GAL4-Hsp70.PB}2 / P{UAS-Nslmb-vhhGFP4}2 ; Hox::XFP y
+
 
Homozygous Hox::XFP with armGAL4 and GAL80+UAS-nano: 









Nanobody Degradation of HOX::XFP Tagged Proteins 
The goal of this study was to degrade HOX proteins specifically during the larval stage 
using the nanobody degradation system.  To do this, first the Hox loci have to be 
modified using CRISPR-mediated HR to create Hox::XFP loci. Second, these Hox::XFP 
transformants must be combined with genetic elements that will allow regulated 
expression of the nanobody and degradation of the HOX::XFP proteins. 
 chiRNA for CRISPR-mediated HR 3.1
The first step in implementing CRISPR-mediated HR is to design chiRNA. chiRNA 
specific for Scr, Antp, and Ubx were designed to be as close to the stop codon as possible. 
20 nt of sequence within the 3’ end of each Hox was chosen as the target for a DSB by a 
chiRNA/Cas9 riboprotein. This target sequence was the closest 20 nt of sequence to the 
TAG stop codon with a NGG PAM sequence. Table 5 shows: the sequences of the 3’ end 
of each Hox (Scr, Antp, and Ubx), the primers used to create the specific chiRNA, and 
confirmation of insertion into the expression plasmid. 
 Repair Vectors for CRISPR-mediated HR 3.2
I created six repair vectors: 5’Scr::GFP loxP y+loxP 3’Scr, 5’Scr::tag loxP y+loxP 3’Scr, 
5’Antp::CFP lox2272 y+lox2272 3’Antp, 5’Antp::tag lox2272 y+lox2272 3’Antp, 
5’Ubx::YFP loxP y+loxP 3’Ubx, and 5’Ubx::tag loxP y+loxP 3’Ubx (annotated sequence 
in Appendix A.d). The tag consists of the 17 aa epitope of GFP (17aa) and a 3X FLAG 
peptide. When integrated, they will create the following six novel HOX fusion proteins: 
SCR::GFP, SCR::17aa::3XFLAG, ANTP::CFP, ANTP::17aa::3XFLAG, UBX::YFP, and 























































Table 5. The Design Strategy of chiRNAs. 
The matching 20 nt guide sequence before a PAM sequence (NGG) is highlighted in each 
of the three Hox loci for: 3’ end of the gene, the double-stranded primer oligonucleotide 
pair for insertion into the chiRNA expression plasmid, and the sequence analysis of the 
ligated chiRNA. Legend: 20 nt guide sequence (bold and underlined), NGG PAM 
sequence (bold and italicized), TAG stop codon or terminator (bold), pU6 promoter 







Figure 22. Novel Proteins Produced from HOX Protein Fusions. 
Abbreviations: SCR, Sex combs reduced; GFP, green fluorescence protein; ANTP, 
Antennapedia; CFP, cyan fluorescence protein; UBX, Ultrabithorax; YFP, yellow 







 Screens of Injection Flies for CRISPR Germline 3.3
Transformation 
3.3.1 Injection of Flies with P Element or Frost 
P element mediated transgenesis requires injection of both a P element plasmid and a 
helper plasmid. P elements insert into the genome with an efficiency of between 5 and 20 
% (Dr. Anthony Percival-Smith, personal communication).  P element and a Δ2-3wc 
helper plasmid were injected into embryos and these gave 13 fertile, viable G0 progeny, 
of which none produced w+ progeny (Table 6). 
Frost (Fst) is a Drosophila cold tolerance gene (Colinet et al., 2010) that has been 
targeted for CRISPR-mediated HR previously with an efficiency of 10% (Dr. Anthony 
Percival-Smith, personal communication). Three CRISPR components; Cas9 vector, Fst 
chiRNA vector, and Fst repair vector, were injected into embryos to test the 
recombination efficiency. 63 fertile, viable G0 progeny were recovered, of which none 
produced w+ progeny (Table 6).  
3.3.2 Injection of Flies with the Cas9 Source Encoded on a 
Plasmid 
Three CRISPR components; Cas9 vector, one of three chiRNA vectors, and one of six 
repair vectors, were injected into embryos and these gave 679 fertile, viable G0 progeny 
(Table 7). No germ line transformation was observed at any of the three loci or with any 
of the six repair vectors when G1 progeny were screened for the y+ phenotype.  
3.3.3 Injection of Flies Expressing Cas9 from a Transgene. 
Injecting one of three chiRNA vectors and one of six repair vectors into Cas9 transgenic 
flies gave 147 fertile, viable adult flies (G0; Table 8).  Two Cas9 transgenic flies were 
used: act-Cas9 where Cas9 is expressed from a constitutively expressed actin5C 
promoter, and nos-Cas9 where Cas9 is expressed from a germline-specific nanos 
promoter.  The G1 generation was screened for successful transformants. One y+ 
candidate transformed fly was identified from the Antp::CFP injected into nos-Cas9 flies 








P Element Fst 
TOTAL 14 82 96 
STERILE 1 19 20 
VIABLE 13 63 76 
Table 6. Screen for Germ-line Transformation with P Element or Frost. 
y w flies were injected with either a P element and a Δ2-3wc helper plasmid or with a Fst 
repair vector,  Fst chiRNA, and a plasmid encoding Cas9. Values represent the number of 










Scr::GFP Scr::tag Antp::CFP Antp::tag Ubx::YFP Ubx::tag 
TOTAL 226 106 160 97 100 149 838 
STERILE 42 15 35 12 17 38 159 
VIABLE 184 91 125 85 83 111 679 
Table 7. Screen for Germ-line Transformation with the Cas9 Source Encoded on a 
Plasmid. 
y w flies were injected with one of six repair vectors, one of three chiRNA plasmids and a 
plasmid encoding Cas9. Values represent the number of vials of flies (each vial contains 
50-100 flies). Abbreviations: Scr, Sex combs reduced; Antp, Antennapedia; Ubx, 
Ultrabithorax; CFP, cyan fluorescence protein; GFP, green fluorescence protein; YFP, 




















nos total 12 8 22 30 16 21 109 
act total 6 1 9 5 15 31 67 
nos sterile 1 3 5 3 2 6 20 
act sterile 0 1 0 0 2 6 9 
nos viable 11 5 17* 27 14 15 72 
act viable 6 0 9 5 13 25 58 
TOTAL 18 9 31 35 31 52 176 
STERILE 1 4 5 3 4 12 29 
VIABLE 17 5 26 32 27 40 147 
y+ observed 0 0 1 0 0 0 1 
Table 8. Screen for Germ-line Transformation with the Cas9 Source Encoded on a 
Transgene. 
nos-cas9 (nos) or act-Cas9 (act) transgenic flies were injected with one of six repair 
vectors and one of three chiRNA plasmids. The set of injections that resulted in a 
successful HR event is marked with an Asterix (*). Values represent the number of vials 
of flies (each vial contains 50-100 flies). Abbreviations: nos, nos-Cas9 flies; act, act-cas9 
flies; Scr, Sex combs reduced; Antp, Antennapedia; Ubx, Ultrabithorax; Fst, Frost; CFP, 
cyan fluorescence protein; GFP, green fluorescence protein; YFP, yellow fluorescence 






progeny showed that the w+ phenotype , which is the marker for integration of the P{nos-
cas9 w+} transposon on the X chromosome, exhibited X linkage with all females being 
w+ and all males being w-.  However, the inheritance of y+ showed no X linkage 
indicating that the y+ gene is integrated on an autosome (The endogenous y locus is on 
the X chromosome; Table 9). The single w+ male is likely a non-disjunction event of the 
X chromosome of a female. 
 Verification of Injected Germline Transformant 3.4
PCR on genomic DNA extracted from transformed flies was performed to verify the 
presence of Antp::CFP. A fragment within Antp was used as a positive control and y w 
genomic DNA spiked with repair template DNA was also used as a control. To 
specifically detect Antp::CFP, the amplified fragments spanned the 5’Antp to CFP 
junction to confirm the 5’Antp::CFP lox2272 y+ lox2272 3’Antp integration (illustrated 
in Figure 23.B). All products were observed as expected for genomic y w DNA and 
genomic y w DNA spiked with Antp::CFP repair template, however y+ genomic DNA 
failed to produce the correct products, indicating the y+ locus is not present at the 
expected locus within the genome (Figure 23.A). 
Furthermore, analysis of the segregation pattern of Lobe, Curly, Tubby, and y+ in the 
progeny from crossing the candidate Antp::CFP flies with fly line 496 (containing 
balancer chromosomes) revealed that the y+ locus is on the 2
nd
 chromosome and not on 
the 3rd chromosome, which contains the Antp locus. 
 Survival Assay 3.5
The efficiency of HR is low and this may be due to a low level of survival to the 
injection.  To determine the survival index, the number of embryos injected was counted 
along with larval, pupal, and adult survivers (Table 10).  The survival of injected 
embryos was 4.9% to larva and 3.0% to eclosed adults.  This is low as generally the goal 












Male 37 y+ w- 
Male 33 y- w- 
Male 1 y- w+ 
Female  51 y+ w+ 
Female 64 y- w+ 
Table 9. Progeny from Cross Between Male Transformant Candidate and Female y 
w. 









Figure 23. PCR of Genomic DNA Extracted from Transformants and Illustration of 
the Associated Amplified Fragments.  
(A) PCR gel image displaying amplified fragments flanked by 1 kb+ DNA Ladder to 
indicate sizes in base pairs (bp). Lanes 1-3 used genomic DNA from y w flies as template, 
lanes 4-6 used genomic DNA from y w flies that was spiked with Antp::CFP repair 
vector DNA as template, and lanes 7-9 used genomic DNA of y+ transformant fly 
candidates as template. (B) The amplified fragments and their expected sizes (in bp) are 
illustrated compared to the transgene: 5’Antp::CFP lox2272 y+ lox2272 3’Antp. The 























nos-Cas9 Antp::CFP 210 9 4 4 4.3 1.9 
nos-Cas9 Antp::CFP 215 12 2 2 5.6 0.9 
nos-Cas9 Antp::tag 210 14 9 9 6.7 4.3 
nos-Cas9 Antp::tag 210 29 12 11 13.8 5.2 
act-Cas9 Scr::GFP 228 3 0 0 1.3 0.0 
act-Cas9 Scr::tag 326 5 1 1 1.5 0.3 
act-Cas9 Ubx::YFP 264 4 1 1 1.5 0.4 
act-Cas9 Ubx::tag 293 2 1 1 0.7 0.3 
y w P element 210 7 7 8 3.3 3.8 
y w Fst 191 22 25 26 11.5 13.6 
y w Fst 215 11 6 4 5.1 1.9 
y w Fst  206 7 7 7 3.4 3.4 
 
Average: 232 10 6 6 4.9 3.0 
Table 10. Rate of Survival to Injections. 
Abbreviations: Antp, Antennapedia; Scr, Sex combs reduced; Ubx, Ultrabithorax; Fst, 
Frost; CFP, cyan fluorescence protein; GFP, green fluorescence protein; YFP, yellow 







 Fly Lines with Nanobody Components 3.6
Multiple balanced fly lines have been generated. 
From crossing scheme 1, two fly lines homozygous on the 2
nd
 chromosome for the 
GAL80 and UAS-nano with a balanced lethal third chromosome were created (referred to 
as GAL80+UAS-nano 7108 and GAL80+UAS-nano 7019). The two lines differ in the 
location and expression activity of the GAL80 insertion in the chromosome. 
From crossing scheme 2, two fly lines were created with a balanced 3
rd
 chromosome. The 
2
nd
 chromosome is either homozygous for GAL4(hs), referred to as the GAL4(hs) stock, 
or homozygous for UAS-nano, referred to as the UAS-nano stock. 
 Summary of Results 3.7
A summary of plasmids and flies that were obtained and created as well as experiments 
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Table 11. Summary of Results. 
Plasmids and flies that were obtained and created as well as experiments conducted are 







 Efficiency and Optimization 4.1
CRISPR/Cas9 genome editing in Drosophila and many other organisms has only been 
established for two years. Several groups have performed CRISPR/Cas9 genome editing 
in Drosophila with differing methods of supplying the Cas9 protein and chiRNA 
components (Bassett et al., 2013; Gratz et al., 2013; Kondo & Ueda, 2013; Ren et al., 
2013; Sebo et al., 2014; Yu et al., 2013).  In genome editing there are two distinct 
approaches employed to repair a DSB: first is NHEJ which creates small deletions, and 
HR, which creates precise genome modifications.   
The efficiency of NHEJ in Drosophila is well documented.  Initial mutagenesis with 
CRISPR involved co-injection of two plasmids into syncytial blastoderm Drosophila 
embryos; one plasmid expressing Cas9 under the Hsp70 promoter and one driving 
chiRNA expression through the U6 gene promoter (Gratz et al., 2013). The efficiency of 
mutagenesis was low, at 5.9% of injected flies giving rise to a mutant offspring; however, 
they were successful in demonstrating that full deletions of sequence was possible (Gratz 
et al., 2013). An alternative means that has been applied in Drosophila involves in vitro 
transcription to synthesize Cas9 mRNA and chiRNA that are then co-injected into 
syncytial blastoderm embryos.  This method achieves higher mutagenesis rates, up to 
80%, making it possible to target multiple loci simultaneously throughout the genome 
(Bassett et al., 2013; Yu et al., 2013). Differences in efficiency may be explained by 
lower expression levels of Cas9 protein and chiRNA from injected plasmids relative to 
direct injection of Cas9 and chiRNA mRNA (Bassett & Liu, 2014).  Another method 
uses transgenic flies to express Cas9 in the germline and express the chiRNA 
ubiquitously, leading to higher efficiency of mutagenesis with up to 90% of flies 
producing mutant offspring and allowing the creation of longer deletions of up to 1.6 kb 
(Kondo & Ueda, 2013). However, producing a new transgenic fly for each chiRNA is 
very time consuming, as is the removal of the Cas9 and chiRNA transgenes after 
mutagenesis (Bassett & Liu, 2014). An alternative to this method is to inject chiRNA 





mutagenesis since Cas9 expression is limited to the germline and can yield efficiencies of 
12-75 % (Ren et al., 2013; Sebo et al., 2014). Most of these methods created mutants via 
deletions or disruptions to genes; however, HR when a donor template is supplied creates 
precise genomic alterations.  
HR of a DSB requires either endogenous homologous sequences or exogenously 
introduced sequences.  When exogenously introduced sequences are used to repair a 
DSB, the repaired DSB has the sequence of the exogenous DNA allowing precise 
genome editing.  The donor template supplying exogenous sequence may come in two 
forms. One is in the form of short (around 200 nt in length) single-stranded DNA 
(ssDNA) oligonucleotides, which can be used to integrate short transgene sequences. The 
second form of donor template, and the one used in this study, is longer double-stranded 
DNA (dsDNA) constructs containing hundreds to thousands of nt of homologous 
sequence on either side of the DSB site, which is capable of integrating longer sequences 
(Beumer & Carroll, 2014). For example, Bassett et al. (2013) used longer homology arms 
to insert a 1.8 kb cassette with a 4% efficiency rate. This technique can be used in 
conjunction with site-specific recombinase sites (such as loxP) to delete, replace, or 
otherwise modify intervening sequence (Bassett & Liu, 2014). The process of using 
longer dsDNA constructs as repair vectors has a relatively low efficiency, but it allows 
the use of marker genes, which is particularly advantageous simplifying identification of 
HR events (Bassett et al., 2013).  In addition to positive markers, negative selectable 
markers, such as UAS-rpr outside of the homology arm, can also be used to optimize 
homologous targeting by enabling selection against non-homologous integrations (Baena-
Lopez et al., 2013). Evidence has suggested that 1 kb of homology at either side of the 
integration site is sufficient to allow efficient HR, simplifying the construction of these 
vectors (Bassett et al., 2013). Larger homology arms enable the integration of longer 
features, for example tagging with fluorescent proteins such as GFP (Bassett & Liu, 
2014). When a protein (such as GFP) is fused to an endogenous gene, expression of the 
protein is subject to the same transcriptional and post-transcriptional controls as the 
endogenous gene, and therefore the tag is expressed at similar levels of functionality and 





stranded plasmid containing the GFP-coding sequence flanked by 1.4 and 1.7 kb 
homology arms from the wingless (wg) locus was injected into double transgenic nos-
cas9, wg-chiRNA fly embryos to produce an in-frame insertion of GFP within the wg 
coding region, leading to a secreted Wg::GFP protein (Port et al., 2014). 38% of the 
offspring of injected embryos expressed a secreted GFP protein in the Wg expression 
pattern (Port et al., 2014). Comparison of the integration efficiency across different 
CRISPR methods is difficult because of the use of different chiRNAs, donors, and target 
genes in each study. Roughly though, when all three DNA components (Cas9, chiRNA, 
and donor) are injected together, 0.3% of offspring integrated the exogenous sequence at 
the target site (Gratz et al., 2013). Larger constructs were integrated at a rate of 0-11 % 
by injecting the donor and chiRNA plasmids into Cas9 transgenic embryos (Gratz et al., 
2014). Injecting donor plasmids into embryos expressing Cas9 and chiRNA transgenes 
produced the highest integration rates of 11-38 % of all offspring (Port et al., 2014). In 
one comparison where the same chiRNA and donor repair vector construct were used 
across all three major CRISPR methods; 3% of all offspring from G0 flies contained the 
integration when a Cas9/chiRNA dual plasmid was co-injected with the donor plasmid, 
which was significantly lower than both the 5-15 % when the chiRNA expressed on a 
plasmid was injected with the donor into single transgenic (Cas9) embryos, and the 19-25 
% when donor plasmid was injected into double transgenic (Cas9 and chiRNA) embryos 
(Port et al., 2015).  
Additionally, the promoter used for chiRNA expression in the chiRNA vector is an 
important element that affects the activity of chiRNA. Port et al. (2014) demonstrated 
that the same chiRNA expressed from different U6 snRNA promoters (U6:1, U6:2, and 
U6:3) have different activities. The previously untested U6:3 promoter gives the most 
potent affect and leads to the highest efficiency of genome editing with the CRISPR 
system (Port et al., 2014). 
When a target gene is cleaved (DSB), either inaccurate NHEJ, or HR when a repair 
template is supplied, are stimulated (Lieber et al., 2003; West, 2003). NHEJ uses the 
NHEJ pathway and HR mainly uses the invasion-mediated synthesis-dependent strand-





pathway, such as lig4 (DNA ligase IV), can significantly improve the proportion of HR 
events (Bozas et al., 2009).  
 Hox::XFP Transformation 4.2
I attempted to induce homologous integration of a GFP, or a derivative of GFP tag, into 
the endogenous Scr, Antp, and Ubx loci, either by co-injection of Cas9 and chiRNA 
plasmids or by injection of a chiRNA plasmid into Cas9 transgenic flies. Both 
approaches involved supplying a repair vector containing a yellow marker gene flanked 
by loxP sites with 1-2 kb homology arms. Unfortunately, the first method yielded no 
edited flies, even after screening through 679 vials of G1 progeny (Table 7).  This 
suggests that the efficiency of genome editing is below 0.2%.  A number of different 
transgenic Cas9 strains have been described and are publicly available, but differ in their 
capacity to make efficient DSBs (Port et al., 2015). Assessments of comparative 
performance revealed substantial differences in their pattern and activity level (Port et al., 
2015). Therefore, two different fly strains, nos-Cas9 and act-Cas9 were used for the 
second CRISPR approach. Screens of 147 vials of progeny (Table 8) resulted in one 
injected fly showing evidence of being edited by the integration of the new sequence; 
however this was off-target.  This suggests that the efficiency of genome editing is less 
than 1%.   
There are many reasons to explain this low efficiency of editing.  First, the survival rate 
of injected flies may explain the low efficiency rate for homologous integration. Only 3% 
of injected embryos eclose (Table 10), which may simply be explained by: poor injection 
technique and lack of experience by the experimenter.  Laura Garofalo and I (working 
50/50 together) injected Fst DNA repair vector along with chiRNA and the Cas9 plasmid 
as a control for the injection method.  Dr. Anthony Percival-Smith found that the 
efficiency of editing was 10%, but screening 63 vials of fertile adult flies (Table 6), we 
found no editing when we should have seen in the range of 3-8 events.  One potential 
explanation is the low 3% survivorship of injected flies. The normal survivorship in good 
injections is in the range of 10-20 % (Dr. Anthony Percival-Smith, personal 





Low efficiency of editing at Scr, Antp, and Ubx, may be due to different editing 
frequencies at each locus.  To date, it is not known how many genomic target sites can be 
effectively edited in CRISPR/Cas experiments because most previous studies do not 
report results of non-editing (Bassett et al., 2013; Lee et al., 2014; Ren et al., 2014; Zhang 
et al., 2014). To date there has been no systematic study on the range of editing rates at 
different loci.  Furthermore, most experiments have not attempted to insert large 
sequences, such as the ~6 kb in this study.  
Fly lines containing components for the GFP-nanobody degrader (NSlmb-vhhGFP4; 
“nanobody”) were successfully generated with relevant balanced background genotypes 
for use in this study. The nanobody components (the UAS driven nanobody, UAS-nano; 
GAL4 under control of a hsp, GAL4(hs);  GAL4 under control of the armadillo 
promoter, armGAL4; and the UAS-nano expressed alongside a ts GAL80 negative 
regulator of GAL4, GAL80+UAS-nano) were crossed to create flies that are balanced on 
the chromosome 3 and homozygous for the nanobody component on chromosome 2. In a 
few crosses, flies that are homozygous for the desired genotype change (Hox::XFP) and 
containing one UAS-nanobody source and one GAL4 source can be created.  
 Future / Next Steps 4.3
4.3.1 Germline Transformants 
Co-injections of relevant chiRNA and repair templates in Cas9 transgenic flies will result 
in the generation of the six Hox::XFP (Scr::GFP, Scr::tag, Antp::CFP, Antp::tag, 
Ubx::YFP, and Ubx::tag) transformants. Once y+ transformants have been identified, 
these heterozygous transformants can be crossed with the generated single nanobody 
component balanced stock lines. 
To test whether combinations of HOX proteins work together to determine the tarsus, the 
use of single, double and triple Hox::XFP transformants is required so that multiple HOX 
(SCR, ANTP, or UBX) can be degraded at the same time.  To create double and triple 
mutants, single mutant Hox::XFP lines must first have the yellow (y+) marker gene 
removed. Removal of the y
+





Cre recombinase source and site-specific recombination between the loxP sites. For the 
Scr and Ubx integration events, the y
+
 marker has been flanked with loxP sites. For Antp, 
the y
+
 is flanked with lox2272 sites that do not recombine with loxP, which is important 
to allow multiple, sequential recombination events, especially of Scr::GFP Antp::CFP 
genotypes, which are close together on the chromosome. Co-injection of relevant 
chiRNA and Hox::XFP repair vectors would establish transformants with the secondary 
and/or tertiary transgene integrations. 
4.3.2 Homozygous Hox::XFP with Nanobody Components 
The Hox::XFP transformants may then be crossed to generate heterozygous Hox::XFP 
with all four single nanobody components (GAL4(hs), UAS-nano, GAL80+UAS-nano, 
and armGAL4). A few simple crosses will generate the homozygous Hox::XFP with 
GAL4(hs) and UAS-nano as well as the homozygous Hox::XFP with armGAL4 and 
GAL80+UAS-nano.  These two fly lines can be exposed either to a 37ºC heat shock at 
the third larval stage to activate expression of the nanobody using hsp-GAL4, or to 29ºC 
to inactivate GAL80. This would cause degradation of the tagged HOX proteins within 
the developing larva during the stage that determination of segment identity occurs. The 
tarsi of the resulting mature adult can be analyzed to determine whether the tarsus has 
been transformed to an arista.  
4.3.3 Expected Results 
If the requirement of ANTP is conserved in insects, the degradation of ANTP will result 
in a tarsus to arista transformation on all legs, as is observed in Tribolium. However, if 
this is not the case, the use of the other Hox::XFP transformants is required to test the 
alternative hypotheses.   
One alternate is that SCR is responsible for tarsus determination or that multiple Hox 
genes may be working together to determine tarsus development. Tarsus to arista 
transformations in one of these cases would suggest that HOX requirement for tarsus 





Another alternate is that none of the three HOX proteins, ANTP, SCR, or UBX, are 
required for tarsus determination in Drosophila and the mechanism of determination is 
HOX-independent. 
 Conclusion 4.4
Establishing CRISPR mediated HR was difficult and had a very low efficiency. However, 
the initial steps have been completed and the system is ready for further experimentation. 
Hox::XFP transformants can be used in conjunction with expression of the nanobody and 
subsequent recombination events to test the hypotheses and further define the role of 
HOX in tarsus determination. The system is established to determine which HOX protein 
is required for tarsus determination in Drosophila melanogaster and whether HOX 
requirement for tarsus determination is conserved in insects. This information will 
provide insight into the scope of conservation of requirement of genetic mechanisms of 
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Appendix A. Sequences for CRISPR 
Annotated sequences of (a) codon‐optimized Cas9 under the control of the Drosophila hsp70 promoter and 
3’ UTR (Gratz et al., 2013), (b) chiRNA expression vector for generating site‐specific, U6‐driven chiRNAs 
(Gratz et al., 2013), (c) the pFUS_A vector used as the backbone for the repair vectors, and (d) the six 
repair vectors used to add a GFP derivative tag to Hox with y+ marker gene flanked by loxP sites. 
A.a. pHsp70-Cas9 









































































































A.b. chiRNA Expression Vector pU6-BbsI-chiRNA  
Dm snRNA:U6:96Ab promoter 
BbsI sites for inserting guide sequence 












A.c. pFUS_A Vector to Insert Repair Sequence 
pFUS_A backbone for  repair vector sequences 
Bsa1 recognition site 





















































A.d. Repair Vectors 
A.d.1 Scr::GFP 
















































































































































































5’ and 3’ homology arms 



































































































































5’ and 3’ homology arms 
CFP 
modified aa sites 
lox2272 site 
y+ marker 





















































































































































5’ and 3’ homology arms 





































































































































































































































































































5’ and 3’ homology arms 













































































































































Appendix B. List of Primers. 
(a) List of primers and their sequences used for: integrating 20 nt of target sequences into chiRNA, 
generating the six repair vectors, colony PCR screening for candidate repair vectors, and genomic 
extraction PCR of Antp::CFP transformant flies. (b) Forward and reverse primer pairs with corresponding 
DNA template for: generating the six repair vectors (fragment 1, 2, and 3), colony PCR screening for 





B.a. List of Primers 
Primer Name Sequence 
chiRNA 
 F.UbxChi 5’CTTCGCGGCGGCGGCGGTCCAAGG 3’     (5’phosphate) 
R.UbxChi 5’AAACCCTTGGACCGCCGCCGCCGC 3’     (5’phosphate) 
F.AntpChi 5’CTTCGAGCCGGGATCCGGAGGCGA 3’     (5’phosphate) 
R.AntpChi 5’AAACTCGCCTCCGGATCCCGGCTC 3’      (5’phosphate) 
F.ScrChi 5’CTTCGAACATCGTACCCTACCACA 3’       (5’phosphate) 
R.ScrChi 5’AAACTGTGGTAGGGTACGATGTTC 3’       (5’phosphate) 
Repair Vectors 
 F.17FLAG 5’AACGTCTATATCGACTACAAAGACCATGACGGTG 3’ 
R.17FLAG 5’GTCTTTGTAGTCGATATAGACGTTGTGGCTGTTG 3’ 
F.UBXXFP 5’CACTTAGATCAGGTGAGCAAGGGCGAGGAGCTG 3’ 
R.UBXXFP 5’GCCCTTGCTCACCTGATCTAAGTGTCCACCTTG 3’ 
F.ANTPXFP 5’AACAGTCCGCAGGTGAGCAAGGGCGAGGAGCTG 3’ 
R.ANTPXFP 5’GCCCTTGCTCACCTGCGGACTGTTGGGTGGTG 3’ 
F.SCRXFP 5’CACCTAAGCGCAGTGAGCAAGGGCGAGGAGCTG 3’ 
R.SCRXFP 5’GCCCTTGCTCACTGCGCTTAGGTGCGCGAACTG 3’ 
F.UBX17 5’CACTTAGATCAGATCCTGGGGCACAAGCTGGAG 3’ 
R.UBX17 5’GTGCCCCAGGATCTGATCTAAGTGTCCACCTTG 3’ 
F.ANTP17 5’AACAGTCCGCAGATCCTGGGGCACAAGCTGGAG 3’ 
R.ANTP17 5’GTGCCCCAGGATCTGCGGACTGTTGGGTGGTG 3’ 
F.SCR17 5’CACCTAAGCGCAATCCTGGGGCACAAGCTGGAG 3’ 
R.SCR17 5’GTGCCCCAGGATTGCGCTTAGGTGCGCGAACTG 3’ 
F.5Ubx 5’CAGCTAGGTCTCGCTATCTCCAAAATGCCAAGTTAACATG 3’ 
F.x5Antpx 5’CAGCTAGGTCTCGCTATCTCTTCGGCCTCCTACCCCTC 3’ 
F.5Scr 5’CAGCTAGGTCTCGCTATTTGTGGCCACGGCCACAGCAG 3’ 
F.x5Scrx 5’CAGCTAGGTCTCGCTATGAATAGTTTTCGGGGGCGAC 3’       
R.5XFP 5’CAGCTAGGTCTCCCATGTTACTTGTACAGCTCGTCCATG 3’ 















R.loxPUbx 5’CAGCTAGGTCTCCCGCCGTATGAACGGAGCCTGCGGGTC 3’ 
R.xloxPUbxx 5’CAGCTAGGTCTCCCGCCCAAACGGTTTGTCGCACTCCTC 3’         
F.lox2272Antp 5’CAGCTAGGTCTCGGGACATAACTTCGTATAGGATACTTTATACG
AAGTTATGATCGACGGAGTCTACCCAC 3’ 
R.lox2272Antp 5’CAGCTAGGTCTCCCGCCGCTTTCCGCTTTGCAGCCCTTTC 3’ 
F.loxPScr 5'CAGCTAGGTCTCGGGACATAACTTCGTATAGCATACATTATACG
AAGTTATGACGCGTGGCACTTTTCGGGTAC 3’ 
R.loxPScr 5’CAGCTAGGTCTCCCGCCGCGAAAATCAGTATGGTTCCGAC 3’ 
R.xloxPScrx 5’CAGCTAGGTCTCCCGCCTCGACAGCTTTGTCTGCTCATC 3’      
F.CFP1 5’ACCACCCTGACCTGGGGCGTGCAGTGCTTCAGCCGC 3’ 







F.S2.a 5’ CTGGCAGTTCCCTACTCTCG 3’   
R.S2.a 5’ GGTAAATCAGCGGGCTGCGTTCG 3’  
F.S1.S2.b 5’ CAGGGAAAGTTCAACTTAATCGC 3’ 
R.S2.b 5’ CTGTCCTGGCTGGTCTAGACGTC 3’ 
Genomic 
extraction PCR  
F.x5ANTPx 5’CAGCTAGGTCTCGCTATCTCTTCGGCCTCCTACCCCTC 3’ 
R.CFP1 5’GCACTGCACGCCGGTGGTCAGGGTGGTCACGAGGGTG 3’ 
R.5XFP 5’CAGCTAGGTCTCCCATGTTACTTGTACAGCTCGTCCATG 3’ 
F.S1.S2.b 5’CAGGGAAAGTTCAACTTAATCGC 3’ 
R.S1.Antp 5’GTTTAGGTTTGTTCACGCGAAG 3’ 









B.b. PCR Primers and Templates 
DNA template 1 DNA template 2 Forward Primer Reverse Primer 
Repair Vector Fragment 1 
UBXTT  F.17FLAG R.5FLAG 
eYFP  F.UBXXFP R.5XFP 
pEGFP  F.SCRXFP R.5XFP 
pEGFP  F.ANTPXFP R.CFP1 
pEGFP  F.CFP1 R.CFP23 
pEGFP  F.CFP23 R.5XFP 
pEGFP  F.UBX17 R.17FLAG 
pEGFP  F.SCR17 R.17FLAG 
pEGFP  F.ANTP17 R.17FLAG 
y w  F.5Ubx R.UBXXFP 
y w  F.5Scr R.SCRXFP 
y w  F.x5Antpx R.ANTPXFP 
y w  F.5Ubx R.UBX17 
y w  F.x5Scrx R.SCR17 
y w  F.x5Antpx R.ANTP17 
ANTPXFP.CFP1 CFP1.CFP23 F.ANTPXFP R.CFP23 
CFP1.CFP23 CFP23.5XFP F.CFP1 R.5XFP 





x5Antpx.ANTPXFP ANTPXFP.5XFP F.x5Antpx R.5XFP 
5Scr.SCRXFP SCRXFP.5XFP F.5Scr R.5XFP 
5Ubx.UBXXFP UBXXFP.5XFP F.5Ubx R.5XFP 
UBX17.17FLAG 17FLAG.5FLAG F.UBX17 R.5FLAG 
SCR17.17FLAG 17FLAG.5FLAG F.SCR17 R.5FLAG 
ANTP17.17FLAG 17FLAG.5FLAG F.ANTP17 R.5FLAG 
5Ubx.UBX17 UBX17.5FLAG F.5Ubx R.5FLAG 
x5Scrx.SCR17 SCR17.5FLAG F.x5Scrx R.5FLAG 
x5Antpx.ANTP17 ANTP17.5FLAG F.x5Antpx R.5FLAG 
Repair Vector Fragment 2 
y+ (digested miMIC) F.loxPy R.loxy 
y+ (digested miMIC) F.lox2272y R.loxy 
Repair Vector Fragment 3 
y w  F.loxPScr R.loxPScr 
y w  F.loxPScr R.xloxPScrx 
y w  F.loxPUbx R.loxPUbx 
y w  F.loxPUbx R.xloxPUbxx 
y w  F.lox2272Antp R.lox2272Antp 
Colony PCR Screening 
white bacteria colony F.S2.a R.S2.a 





Genomic Extraction PCR (of y+ transformants) 
y w  F.x5ANTPx R.CFP1 
y w  F.x5ANTPx R.5XFP 
y w  F.S1.S2.b R.S1.Antp 
y w  F.S1.S2.b R.lox2272Antp 
y+ transformants  F.x5ANTPx R.CFP1 
y+ transformants  F.x5ANTPx R.5XFP 
y+ transformants  F.S1.S2.b R.S1.Antp 
y+ transformants  F.S1.S2.b R.lox2272Antp 
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Figure 2. Makarova et al., 2011. 
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Figure 7. Gilbert, 2013 modified from Postlethwait & Schneiderman, 1971.  
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Figure 10. Rothbauer et al., 2006. 
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Figure 11. Kubala et al., 2010. 
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Figure 12 and 13. Caussinus et al., 2012. 
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